David J. Chung

3.1k citations
99 papers · 1.3k indexed · h-index 19
Topics
Multiple Myeloma Research and Treatments (67 papers)Protein Degradation and Inhibitors (16 papers)Immunotherapy and Immune Responses (14 papers)

In The Last Decade

David J. Chung

88 papers receiving 1.3k citations

Peers

David J. Chung
Comparison fields: 5 of 89
  • Hematology 578
  • Molecular Biology 521
  • Oncology 506
  • Immunology 453
  • Infectious Diseases 116
Replace Cindy Jacobs with:
Cindy Jacobs United States
Antonios Bayas Germany
Bernard Gregory United Kingdom
Erin Gatza United States
Divino Deoliveira United States
Roberto Díaz‐Peña Spain
Yasuto Araki Japan
Pervinder Sagoo United Kingdom
K. O. Kliche United States
Dimitrios Tzachanis United States
David J. Chung relative to Cindy Jacobs United States Cindy Jacobs's profile →
Citations per field
00.5×7.7×
Cindy Jacobs · 1×
Citations per year

Countries citing papers authored by David J. Chung

Since Specialization
Citations

This map shows the geographic impact of David J. Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Chung more than expected).

Fields of papers citing papers by David J. Chung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Chung. The network helps show where David J. Chung may publish in the future.

Co-authorship network of co-authors of David J. Chung

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Chung. A scholar is included among the top collaborators of David J. Chung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Chung. David J. Chung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 7
3 1
4 30
5 4
6 5
7 1
8 41
9 7
10 11
11 0
12 2
13 2
14 25
15 38
16 51
17 65
18 16
19 61
20 39

About David J. Chung

David J. Chung is a scholar working on Hematology, Oncology and Immunology, having authored 99 papers that have together received 1.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (67 papers), Protein Degradation and Inhibitors (16 papers) and Immunotherapy and Immune Responses (14 papers). The work is most often cited by research in Hematology (578 citations), Biological Psychiatry (66 citations) and Immunology (453 citations). David J. Chung has collaborated with scholars based in United States, Sweden and Norway. Frequent co-authors include James W. Young, Sergio Giralt, Alexander M. Lesokhin, Sean M. Devlin, Heather Landau, Emanuela Romano, Hani Hassoun, Marco Rossi, Jianda Yuan and Nikoletta Lendvai. Their work appears in journals such as Science, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026